Bristol-Myers Squibb Co
BMYHealthcare|Drug Manufacturers - General|USA
$58.23
-1.10 (-1.85%)
DCF (FCF)
$68.81
Earnings Power
$30.07
About
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Stock Price
+2.6%(1Y)
Pipeline Summary
564 total trials173
Phase 1
194
Phase 2
114
Phase 3
22
Phase 4
Completed: 367Unknown: 24Active: 47Recruiting: 43Terminated: 47NOT_YET_RECRUITING: 9Withdrawn: 21NO_LONGER_AVAILABLE: 3AVAILABLE: 2SUSPENDED: 1
Active Trials (90)
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
NCT03383458Hepatocellular Carcinoma
Phase 3Active
Enrollment: 545 participants
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
NCT02632409Various Advanced Cancer
Phase 3Active
Enrollment: 709 participants
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
NCT04495296Advanced Cancer
Phase 1Phase 2Recruiting
Enrollment: 320 participants
A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer
NCT05334719Stomach Neoplasms
Active
Enrollment: 500 participants
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
NCT04396821Advanced Cancer
Phase 1Phase 2Active
Enrollment: 150 participants
BioScore
7.6/10
Buy
Ownership
Recent Insider Trades
Elkins David VSELL
2026-04-0130,000 shares @ $61.67
Elkins David VSELL
2025-09-0256,000 shares @ $47.33
Short Bartie WendySELL
2025-08-02378 shares @ $44.23
Hickey BenjaminSELL
2025-05-0997 shares @ $38.01
Hirawat SamitBUY
2025-04-254,250 shares @ $47.58
Recent News
2026-04-02 16:00:40
2026-04-01 12:33:52
2026-04-01 12:00:07
2026-03-31 11:00:05
2026-03-28 12:00:03
Data last updated: Apr 7, 2026, 02:27 PM